This audit is for endocrinology and diabetes higher specialty trainees deciding whether StudyPRN can be their primary SCE bank. Checked on 20 July 2026, StudyPRN is a genuine SCE specialist and its Endocrinology & Diabetes bank maps almost one-to-one onto the official nine-domain blueprint. The principal limitation is not coverage but modality: dynamic-function interpretation and fast-moving guideline therapeutics need live data and current sources that a static bank can rehearse but not replace.
What StudyPRN offers for SCE Endocrinology and Diabetes right now
StudyPRN's Endocrinology & Diabetes SCE bank lists 891 test questions, of which 100 are assigned to a three-hour mock exam, priced at £189.00 with subscription periods from 3 to 12 months (vendor-reported, 20 July 2026). The vendor states it "mirrors the MRCP SCE Endocrinology & Diabetes blueprint" and lists topic areas that match the Federation's domains. No adaptive or AI feature is described—this is a curated, blueprinted bank with a timed mock, and it is honest about that. StudyPRN builds specifically for SCEs across a dozen specialties, so this is a purpose-built product rather than a subject filter lifted from an MRCP bank.
| Attribute (StudyPRN Endo & Diabetes SCE) | Vendor-reported, 20 July 2026 |
|---|---|
| Question count | 891 (100 assigned to a 3-hour mock) |
| Price | £189.00 |
| Access periods | 3 to 12 months |
| Adaptive/AI | None described |
| Mock exam | Yes, 3-hour, 100-question mock |
| Blueprinting | States it mirrors the MRCP SCE Endo & Diabetes blueprint |
The SCE Endocrinology and Diabetes exam: the official anchor
The SCE is two papers of 100 best-of-five questions each (200 total), each three hours, one day, computer-based, one mark per correct answer, no negative marking, run annually (next sittings 11 November 2026 and 10 November 2027). The Federation's blueprint distributes the 200 questions across nine domains, led by thyroid (about 32), complications of diabetes (about 29), diabetes mellitus and its delivery of care (about 25) and an "other" catch-all (about 25), with adrenal and pituitary at about 22 each, gonads about 19, parathyroid/calcium about 16 and diabetic emergencies/perioperative about 10. The official document is your source of truth; a vendor's alignment claim is credible here but still a claim.
Live count broken down by blueprint domain
The number that matters is not 891 but its distribution across the nine domains. StudyPRN's own topic list reads: diabetes mellitus (diagnosis, general management, delivery of care); diabetic emergencies and management during acute illness/surgery; complications of diabetes; hypothalamus and pituitary; thyroid; adrenal; gonads; parathyroid/calcium; and "other." That is a one-to-one match with the Federation's blueprint, which is the strongest structural feature of the product: you can build a real blueprint-coverage matrix from it. With 891 items across nine domains you have ample volume—roughly four to five times the size of a single paper—so per-domain depth should be adequate even for the smaller slices, but confirm the current per-domain counts inside the product, since a large total can still leave parathyroid/calcium or gonads thinner than the blueprint implies.
Question style: recall versus application
Sample two or three items per domain and score the cognitive level. The items that transfer are application-level: a vignette with biochemistry, a plausible five-option differential and a single best next investigation or management step—exactly the discrimination the best-of-five format rewards. Endocrinology lends itself to strong data-interpretation stems (dynamic function tests, calcium and thyroid panels, sodium disturbances), and a good bank leans into these rather than into naming associations. Check stem length and option plausibility yourself: if two or three options are routinely indefensible, the item trains recognition, not reasoning. On sampling, expect StudyPRN to be usefully application-weighted with quantitative stems, but verify that dynamic-function reasoning is tested at exam depth rather than as single-fact recall.
Jurisdiction and recency
Diabetes and endocrine therapeutics change quickly, so check a stratified sample against current UK guidance and record the review date. GLP-1 receptor agonists and SGLT2 inhibitors, insulin regimens and technology (continuous glucose monitoring, closed-loop systems), thyroid and adrenal replacement, and osteoporosis and calcium management all move with NICE guidance, specialty-society standards (for example ABCD/Diabetes UK, the Society for Endocrinology and the Association for Clinical Biochemistry reference ranges) and the SmPC/eMC for individual agents. Read every drug-detail and target item against those sources rather than the explanation alone, and note when you last verified it. A blueprinted bank is only as current as its last editorial pass; treat therapeutics items that predate the latest guidance as provisional until confirmed.
Format gap: what a Q-bank cannot fully rehearse
State it plainly: a standard question bank prepares you for the written best-of-five format, but it cannot fully rehearse the dynamic-testing reasoning, guideline recency and integrated investigation-interpretation the SCE rewards. Interpreting a short Synacthen, an oral glucose tolerance test, a water-deprivation test or a suppression test as an unfolding clinical problem—deciding the next step as results arrive—is a skill built in clinic and on-call, not solely through static single-answer items. Guideline recency is the second gap: a fixed bank lags the frequent updates in diabetes therapeutics. Use StudyPRN to structure, cover and drill the format, and use clinical exposure and current guidance to build the reasoning and currency it cannot.
Duplication and contamination
Assess how often the same concept recurs and how many stems are near-duplicates, because repetition turns completion into recognition. In an 891-item bank, high-yield concepts (diabetic ketoacidosis management, thyroid function interpretation, hyponatraemia) will recur by design as reinforcement; the risk is that on a second pass you answer from memory of the item rather than the medicine, so repeat accuracy climbs while first-attempt ability does not. Protect the signal by holding the 100-question mock back until late, tracking first-attempt separately from repeat accuracy, and importing unseen items for genuine measurement.
Best-fit matrix: where this bank is strongest
| Use case | Fit for StudyPRN Endo & Diabetes SCE |
|---|---|
| Foundation building | Moderate—assumes core endocrine knowledge in place |
| First-pass primary bank | Strong—blueprint-aligned, high volume, timed mock |
| Second bank (add-on) | Moderate—overlap risk with another blueprinted endocrine bank |
| Retake after a fail | Strong—systematic nine-domain re-coverage |
| Final simulation | Good for one 3-hour mock; add unseen mixed blocks |
The bank is strongest as a first-pass primary resource and as a retake scaffold; it is weakest as a standalone final-simulation tool, because one mock cannot supply the unseen exam-condition volume that final readiness needs.
Seven-day plan: StudyPRN for coverage, iatroX for transfer
Give each tool one job. StudyPRN builds and blueprints coverage; iatroX supplies unseen, timed, mixed measurement of transfer. iatroX is not an endocrinology-specific SCE bank—it is the cross-specialty UK/MRCP-level knowledge and unseen-MCQ measurement layer that sits alongside a specialty bank, valuable for the general-medicine reasoning and prescribing safety threaded through endocrine stems and for spaced retrieval of misses.
| Day | StudyPRN (coverage) | iatroX (transfer measurement) |
|---|---|---|
| Mon | 50 items: parathyroid/calcium + gonads | — |
| Tue | Error review; retrieval notes | 20 unseen mixed items, timed |
| Wed | 50 items: pituitary + adrenal | — |
| Thu | 50 items: diabetes complications + emergencies | 20 unseen mixed items, timed |
| Fri | 50 items: thyroid + dynamic-function stems | — |
| Sat | 100-item StudyPRN mock, timed | — |
| Sun | Spaced re-test of the week's misses | 30 unseen mixed items, timed |
No item is practised twice across platforms, keeping the measurement clean per the two-Q-bank rule.
Decision checklist: continue, supplement, switch or stop
Continue with StudyPRN while your blueprint-coverage matrix is filling and first-attempt accuracy on unseen items is rising. Supplement with clinical dynamic-function reasoning, current guideline reading and iatroX for unseen measurement. Switch primary banks only for a measurable, persistent domain gap—not for novelty. Stop adding questions when timed, mixed, first-attempt accuracy plateaus and errors are careless rather than gaps; then move to exam-condition mocks. Decide on measurable gaps, never sunk cost.
Three mistakes this audit is designed to stop
First, over-practising the diabetes and thyroid comfort zones—which already dominate the blueprint—while parathyroid/calcium, gonads and pituitary dynamic-function testing stay thin, so the average climbs but the reliably examined smaller domains remain unaudited. Second, treating dynamic-function items as single-fact recall rather than sequential clinical reasoning: a short Synacthen or water-deprivation result is a decision point, not a trivia answer, and the exam rewards the reasoning that unfolds as results arrive. Third, assuming a static bank's diabetes therapeutics are current—GLP-1 receptor agonists, SGLT2 inhibitors, insulin technology and osteoporosis agents move quickly, so verify every target and drug-detail item against the SmPC/eMC and the latest NICE and specialty-society guidance rather than the explanation alone.
Bottom line
StudyPRN's SCE Endocrinology and Diabetes bank is a strong, honest, blueprint-aligned primary resource whose 891 questions map cleanly onto the nine official domains and whose question style transfers well to the written exam. What it cannot fully rehearse is dynamic-function reasoning and guideline currency, which are built in clinic and against live sources. Use StudyPRN to cover and drill, use clinical exposure and current guidance to reason, and use iatroX to measure transfer on unseen items.
FAQ
Is StudyPRN enough for SCE Endocrinology and Diabetes on its own? For blueprinted coverage it is a strong primary bank—891 items mapping one-to-one onto the nine official domains with a three-hour mock (vendor-reported, 20 July 2026)—but "on its own" it cannot rehearse dynamic-function reasoning or keep pace with fast-moving diabetes guidance, so pair it with clinical exposure and a source of unseen measurement.
Which SCE Endocrinology and Diabetes component does StudyPRN not reproduce well? The unfolding interpretation of dynamic function tests and the currency of rapidly changing therapeutics: a static bank can present the data but not the real-time reasoning of clinic, and its therapeutics inevitably lag the latest NICE and specialty-society updates, so both need reinforcing outside the bank.
How many StudyPRN questions should I complete per day for SCE Endocrinology and Diabetes? Around 40–50 blueprinted items a day for a trainee working clinically, weighted toward the domains your coverage matrix flags as thin, plus a short timed unseen block for measurement; spaced, reviewed coverage beats racing through all 891 without revisiting the misses.
When should I stop using StudyPRN and move to mixed mocks? Move to full mixed mocks once your nine-domain coverage matrix is complete and your first-attempt, timed accuracy on unseen items has stabilised, holding StudyPRN's own 3-hour mock back until that late stage so it works as a genuine unseen simulation.
How should I combine StudyPRN with iatroX without duplicating practice? Assign StudyPRN the coverage job and iatroX the measurement job: cover the nine domains on StudyPRN, then test transfer on iatroX's unseen, timed, mixed blocks, keeping the banks separate so no item is seen twice and your readiness signal stays uncontaminated.
Editorial notes and references
Written by Dr Kolawole Tytler, NHS GP and founder of iatroX. Last checked 20 July 2026. Vendor figures (question counts, pricing, access periods and blueprint-alignment claims) are vendor-reported and change without notice; verify the current position on studyprn.com before purchase. Endocrine prescribing and targets should be taken from the SmPC/eMC and current NICE, CKS and specialty-society guidance. Disclosure: iatroX operates a competing UK question bank and clinical-knowledge platform; here its role is confined to jobs StudyPRN does not claim—cross-specialty knowledge and unseen-MCQ measurement—and iatroX is not a specialty-specific SCE Endocrinology bank. Corrections are welcome via the feedback route on iatrox.com. References: Federation of Royal Colleges of Physicians (MRCP(UK)) SCE format and SCE Endocrinology & Diabetes blueprint; StudyPRN Endocrinology & Diabetes SCE product page (studyprn.com); NICE, CKS and SmPC/eMC for therapeutics; and the iatroX framework pieces on Q-bank percentage and blueprint-coverage matrices. Compare tools on the iatroX comparison hub.
Run a fresh, timed unseen block in iatroX and decide learn, retest, simulate or stop →